Center for Zoonotic and Emerging Infectious Diseases

人畜共患病和新发传染病中心

基本信息

  • 批准号:
    8874236
  • 负责人:
  • 金额:
    $ 108万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Zoonotic and emerging infectious diseases represent an increasing and very real threat to global health, and it is essential that we expand our understanding of the pathogenesis and prevention of these diseases because of the increasing density of human populations, the increased exposure to domestic animal populations, and the crowding of wildlife into limited areas with frequent human contact. To address the growing need for infectious disease research, a COBRE Center of Excellence was established at MSU, with the goal of positioning Montana as a national leader in research on zoonotic infectious diseases. Over the past 9 years, the Center has been extremely successful, resulting in infrastructure development (facilities & equipment), recruitment and support of junior investigators (7 COBRE Projects, 6 new hires, and 20 Pilot Projects), and formation of a cohesive Center of investigators. The synergism of these components has resulted in the establishment of a solid foundation for infectious disease research in the region. Importantly, these efforts have fostered faculty career development and have created a pipeline of new researchers with interest and expertise in infectious disease pathogenesis. With this solid infrastructure foundation in place, we are now ideally poised for Center transition to a sustainable research enterprise. Our long term goal is to maintain a sustainable Center of Excellence that is focused on understanding the mechanisms of pathogenesis, host immune response, and immunotherapeutic development for zoonotic and emerging infectious diseases of regional and worldwide importance. The primary goal of COBRE III is to facilitate transition of the Center into a sustainable entity with state-of-the-art research core facilities and a vibrant research environment. Through COBRE III efforts, we also seek to maintain and enhance the critical mass of investigators needed to support future program initiatives. While the foundation and infrastructure for achieving these goals have been established during COBRE l/ll, there is still a critical need for infrastructure optimization and acquisition of additional researchers in he area of infectious diseases to enrich the group and facilitate programmatic efforts. The transition to Center sustainability will be stimulated by an enhanced Pilot Grants Program that will expand the scope and impact of Center research and increase the number of collaborative efforts leading toward larger program-type grants. Likewise, the transition to Center sustainability will involve solidfying scientific Core structure and optimizing utilization of Core research facilities/resources. Finally, Center transition will be enhanced by career development initiatives such as educational programs and mentoring activities, to meet the needs of all Center associated investigators. Importantly, this Center will continue to be highly interactive and collaborative and will play an important role in expanding the infectious disease research enterprise in Montana.
描述(申请人提供):人畜共患传染病和新出现的传染病对全球健康构成日益严重和非常现实的威胁,由于人口密度的增加、接触家畜种群的增加以及野生动物拥挤在人类频繁接触的有限区域,我们必须扩大对这些疾病的发病机制和预防的理解。为了满足对传染病研究日益增长的需求,密歇根州立大学成立了科布雷卓越中心,目标是将蒙大拿州定位为人畜共患传染病研究的全国领先者。在过去的9年里,该中心取得了极大的成功,在基础设施开发(设施和设备)、招募和支持初级调查人员(7个Cobre项目、6个新招聘人员和20个试点项目)方面取得了巨大成功,并形成了一个有凝聚力的调查中心。这些组成部分的协同作用为该区域的传染病研究奠定了坚实的基础。重要的是,这些努力促进了教师的职业发展,并创造了一批对传染病发病机制感兴趣和专业知识的新研究人员。有了坚实的基础设施基础,我们现在已经为中心向可持续发展的研究企业过渡做好了理想的准备。我们的长期目标是保持一个可持续的卓越中心,专注于了解具有地区和全球重要性的人畜共患病和新出现的传染病的发病机制、宿主免疫反应和免疫治疗发展。Cobre III的主要目标是促进该中心转变为一个可持续发展的实体,拥有最先进的研究核心设施和充满活力的研究环境。通过Cobre III的努力,我们还寻求保持和加强支持未来项目倡议所需的调查人员的临界数量。虽然实现这些目标的基础和基础设施已经在科布雷L/11期间建立,但仍迫切需要优化基础设施并获得更多传染病领域的研究人员,以充实该小组并促进方案工作。过渡时期 TO中心的可持续性将通过增强的试点赠款计划得到刺激,该计划将扩大中心研究的范围和影响,并增加导致更大计划类型赠款的合作努力的数量。同样,向中心可持续性的过渡将涉及巩固科学核心结构和优化核心研究设施/资源的利用。最后,中心过渡将通过职业发展计划,如教育计划和指导活动来加强,以满足所有中心相关调查人员的需求。重要的是,该中心将继续保持高度的互动性和协作性,并将在扩大蒙大拿州的传染病研究企业方面发挥重要作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK T QUINN其他文献

MARK T QUINN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK T QUINN', 18)}}的其他基金

Development of Novel Therapeutics for the Treatment of Alzheimer's Disease
开发治疗阿尔茨海默病的新疗法
  • 批准号:
    10121243
  • 财政年份:
    2016
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    9100428
  • 财政年份:
    2014
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    8705651
  • 财政年份:
    2014
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    9306156
  • 财政年份:
    2014
  • 资助金额:
    $ 108万
  • 项目类别:
MT VET COBRE II CORE A: ADMINISTRATIVE CORE
MT VET COBRE II 核心 A:管理核心
  • 批准号:
    8360158
  • 财政年份:
    2011
  • 资助金额:
    $ 108万
  • 项目类别:
MT VET COBRE II CORE A: ADMINISTRATIVE CORE
MT VET COBRE II 核心 A:管理核心
  • 批准号:
    8168412
  • 财政年份:
    2010
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    7902317
  • 财政年份:
    2009
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    7902316
  • 财政年份:
    2009
  • 资助金额:
    $ 108万
  • 项目类别:
MT VET COBRE CORE A: ADMINISTRATIVE CORE
MT VET COBRE 核心 A:行政核心
  • 批准号:
    7960521
  • 财政年份:
    2009
  • 资助金额:
    $ 108万
  • 项目类别:
MT VET COBRE CORE A: ADMINISTRATIVE CORE
MT VET COBRE 核心 A:行政核心
  • 批准号:
    7721021
  • 财政年份:
    2008
  • 资助金额:
    $ 108万
  • 项目类别:

相似海外基金

Consolidated Biomedical Core Facilities Supporting a Center on Emerging and Zoonotic Infectious Disease Research
支持新发和人畜共患传染病研究中心的综合生物医学核心设施
  • 批准号:
    10372482
  • 财政年份:
    2021
  • 资助金额:
    $ 108万
  • 项目类别:
Center on Emerging and Zoonotic Infectious Diseases
新发和人畜共患传染病中心
  • 批准号:
    10642671
  • 财政年份:
    2020
  • 资助金额:
    $ 108万
  • 项目类别:
Center on Emerging and Zoonotic Infectious Diseases
新发和人畜共患传染病中心
  • 批准号:
    10397670
  • 财政年份:
    2020
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    9100428
  • 财政年份:
    2014
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    8705651
  • 财政年份:
    2014
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    9306156
  • 财政年份:
    2014
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    7902317
  • 财政年份:
    2009
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    7902316
  • 财政年份:
    2009
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    8089421
  • 财政年份:
    2004
  • 资助金额:
    $ 108万
  • 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
  • 批准号:
    8306748
  • 财政年份:
    2004
  • 资助金额:
    $ 108万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了